 Home > Active Ingredient News > Antitumor Therapy > J Clin Oncol: Bentuximab vedodin can significantly reduce the radiation dose of children with high-risk Hodgkin's lymphoma without affecting the efficacy

J Clin Oncol: Bentuximab vedodin can significantly reduce the radiation dose of children with high-risk Hodgkin's lymphoma without affecting the efficacy

 Last Update: 2021-05-08
 Source: Internet
 Author: User

Tags

high power resistor

3 1 fade

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Bentuximab vitoxin is an effective anti-CD30 antibody drug conjugate, which has been approved for the treatment of adult classic Hodgkin's lymphoma (HL).

Lymphoma in children

This open-label, single-arm, multi-center trial included patients (age ≤ 18 years) with stage IIB, IIIB, or IV classic HL.

Of the 77 patients who participated in the study, 27 (35%) achieved complete remission at ERA and did not receive radiation therapy.

In summary, the results of the study show that the integration of Bentuximab Vidotin into the first-line treatment of children with high-risk HL is highly tolerated by the children, which is conducive to significantly reducing the dose of radiotherapy and can be achieved Good curative effect.

Original source:

Monika L Metzger, et al.

ncbi.
nlm.
nih.
gov/33826362/" target="_blank" rel="noopener">Excellent Outcome for Pediatric Patients With High- Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

N-Desmethyl Imatinib 99%

CAS No.: 404844-02-6

Pharma Grade

$1/MT FOB

High purity Octenidine dihydrochloride 98% with best price 70775-75-6 and Octenidine dihydrochloride raw material

CAS No.: 70775-75-6

Pharmacy Grade

$8.8-10/MT FOB

Anti-Cancer Pirespa Powder CAS 53179-13-8 Pirfenidone 5-methyl-1-phenylpyridin-2-one

CAS No.: 53179-13-8

Pharmacy Grade

$4/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.